๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
An open-label, single-arm, multicenter, prospective clinical study of Hanli...
Status
Recruiting
Location
Department of Oncology, The First Affiliated Hospital of Zhengzhou University
Start Date
2022-08-12
Trial ID
NCT05506410
Treatments Being Tested
This is a prospective, open-label, multicenter, randomized controlled study...
Status
Not Yet Recruiting
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2026-05-06
Trial ID
NCT07594899
The goal of this study is to test mosunetuzumab given alone or in combinati...
Status
Recruiting
Location
Brigham & Women's Hospital
Start Date
2025-11-24
Trial ID
NCT07052695
Treatments Being Tested
This is a single arm study to evaluate the efficacy, safety and tolerabilit...
Status
Completed
Location
Clinical Research Alliance, Inc
Start Date
2019-02-19
Trial ID
NCT03846427
Treatments Being Tested
The purpose of the study is to establish the safety and efficacy of zanubru...
Status
Recruiting
Location
Moffitt Cancer Center
Start Date
2024-04-19
Trial ID
NCT06350318
Treatments Being Tested
This is a study for participants with a type of blood cancer called mantle ...
Status
Active Not Recruiting
Location
Alaska Oncology and Hematology, LLC
Start Date
2021-04-08
Trial ID
NCT04662255
Treatments Being Tested
This study aims to evaluate the efficacy of BTK inhibitor Zanubrutinib comb...
Status
Completed
Location
Institute of Hematology & Blood Diseases Hospital
Start Date
2020-06-01
Trial ID
NCT04463953
Treatments Being Tested
To evaluate the efficacy and side effects of Zanubrutinib combined with Obi...
Status
Recruiting
Location
Bing Xu
Start Date
2024-03-31
Trial ID
NCT06553352
Treatments Being Tested
The goal of this clinical trial is to learn the efficacy and safety of zanu...
Status
Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2025-01-01
Trial ID
NCT06959732
Treatments Being Tested
This phase III trial compares the effect of adding sonrotoclax to zanubruti...
Status
Recruiting
Location
Cedars-Sinai Medical Center
Start Date
2026-04-30
Trial ID
NCT07321652